Showing results (1201-1210 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|August 22, 2014
Influence of donor-recipient CYP3A4/5 genotypes, age and fluconazole on tacrolimus pharmacokinetics in pediatric liver transplantation: a population approachVanessa Guy-Viterbo, Henry Baudet, Laure Elens, et al.
Pharmacogenomics|August 22, 2014
Calcineurin inhibitors and hypertension: a role for pharmacogenetics?Arthur D Moes, Dennis A Hesselink, Robert Zietse, et al.
Pharmacogenomics|August 22, 2014
Parkinson's disease pharmacogenomics: new findings and perspectivesArtur F Schumacher-Schuh, Carlos R M Rieder, Mara H Hutz
Pharmacogenomics|August 13, 2013
Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patientsHon-Kit Lee, Miao Hu, Sandra Sh Lui, et al.
Pharmacogenomics|September 13, 2013
Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation scienceM Eileen Dolan, Michael L Maitland, Peter H O'Donnell, et al.
Pharmacogenomics|September 13, 2013
CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case-control studyNikica Miroševic Skvrce, Nada Božina, Lada Zibar, et al.
Pharmacogenomics|September 13, 2013
Human dopamine transporter gene: differential regulation of 18-kb haplotypesYing Zhao, Nian Xiong, Yang Liu, et al.
Pharmacogenomics|October 4, 2013
Pharmacogenetics of topical and systemic treatment of psoriasisRocío Prieto-Pérez, Teresa Cabaleiro, Esteban Daudén, et al.
Pharmacogenomics|December 1, 2015
BRAF in metastatic colorectal cancer: the future starts nowArmando Orlandi, Alessandra Calegari, Alessandro Inno, et al.
Pharmacogenomics|December 1, 2015
The role of ADME pharmacogenomics in early clinical trials: perspective of the Industry Pharmacogenomics Working Group (I-PWG)Larry Tremaine, William Brian, Terrye DelMonte, et al.
Pageof 276